bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.07.28.605515

AraRoot - A Comprehensive Genome-Scale Metabolic Model for the Arabidopsis Root System.

Abstract

Being the first plant to have its genome sequenced, Arabidopsis thaliana (Arabidopsis) is a well-established genetic model plant system. Studies on Arabidopsis have provided major insights into plants physiological and biochemical nature. Methods that allow us to computationally study the metabolism of organisms include the use of genome-scale metabolic models (GEMs). Despite its popularity, currently no GEM maps the metabolic activity in the roots of Arabidopsis, which is the organ that faces and responds to stress conditions in the soil. Weve developed a comprehensive GEM of the Arabidopsis root system - AraRoot. The final model includes 2,682 reactions, 2,748 metabolites, and 1,310 genes. Analyzing the metabolic pathways in the model identified 158 possible bottleneck genes that impact biomass production, most of which were found to be related to phosphorous-containing- and energy-related pathways. Further insights into tissue-specific metabolic reprogramming conclude that the cortex layer in the roots is likely responsible for root growth under prolonged exposure to high salt conditions, while the endodermis and epidermis are responsible for producing metabolites responsible for increased cell wall biosynthesis. The epidermis was found to have a very poor ability to regulate its metabolism during exposure to high salt concentrations. Overall, AraRoot is the first GEM that accurately captures the comprehensive biomass formation and stress responses of the tissues in the Arabidopsis root system.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Esterhuizen, L., Ampimah, N., Yandeau-Nelson, M., Nikolau, B. J., Sparks, E. E., Saha, R.. 2024-07-29. AraRoot - A Comprehensive Genome-Scale Metabolic Model for the Arabidopsis Root System.. https://doi.org/10.1101/2024.07.28.605515

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Mapping a genome-scale in vivo knockout screen to a mechanistic network model identifies VAV2, RASA1, and LEPR as regulators of cardiomyocyte hypertrophy

Cardiomyocyte hypertrophy is a leading clinical predictor of heart failure, yet newly identified candidate genes often remain disconnected from the signaling mechanisms that govern cardiomyocyte growth. We developed a computational-experimental pipeline that integrates genome-scale mouse knockout phenotypes with a logic-based differential equation model of hypertrophic signaling. Among 9,605 genes evaluated by the International Mouse Phenotyping Consortium, 939 knockout lines induced abnormal heart morphology. Directional curation of hypertrophy-related sub-phenotypes followed by interaction-based network expansion mapped 37 genes to the signaling model. Virtual knockdown screening identified five candidates with concordant in vivo and in silico effects: LRIG1 and CBL as predicted negative regulators and VAV2, RASA1, and LEPR as predicted positive regulators. Mechanistic subnetwork analysis linked these candidates to distinct receptor-proximal, Ras, PI3K-AKT, and MAPK signaling axes. In neonatal rat cardiomyocytes, siRNA-mediated depletion of VAV2, RASA1, or LEPR reduced phenylephrine-induced cell growth, supporting their cell-autonomous contribution to hypertrophy. Quantitative phenotyping further validated the predicted decreased cardiac hypertrophy for VAV2 and LEPR knockouts but identified potential age-dependent mechanisms for RASA1 knockout. Overall, this study establishes the application of network models to translate from in vivo phenotypic screens into pathway mechanisms.

systems biology↗

SpaReg: sparsity-based 3D reconstruction of tissue microenvironments at native resolution across morphological and spatial molecular modalities

Tissue microenvironments comprise cellular and acellular components whose three-dimensional (3D) architecture guides disease fate. Direct imaging of intact specimens by light-sheet and multiphoton microscopy, and computational reconstruction from serial sections, have established that 3D spatial context reveals cell and tissue organization inaccessible at single planes. Computational reconstruction in particular can leverage archived human tissue, benefiting from the cost-effectiveness, robustness, scalable storage, workflow compatibility, and century-long pathobiology knowledge of histology, and can integrate multiple spatial modalities. However, sectioning can introduce tears and folds, and computational alignment can further distort tissue integrity. Here we introduce SpaReg, a sparsity-based 3D reconstruction method spanning histology, spatial proteomics and spatial transcriptomics. Across multiple organs, SpaReg robustly reconstructs large tissue volumes with preserved subcellular morphology despite sectioning artifacts. On a standardized histology benchmark, SpaReg achieves the best balance between 3D reconstruction accuracy and tissue integrity, and on spatial transcriptomics benchmarks it ranks among the leading methods while scaling to hundreds of sections and millions of cells in a dataset that several existing methods fail to process. Preservation of subcellular morphology by SpaReg also enables training of a Hematoxylin and Eosin (H&E)-based epithelial, T and B cell classifier, generating single-cell-resolved 3D maps directly from H&E. Applied to pancreatic tissue containing pancreatic ductal adenocarcinoma arising from an intraductal papillary mucinous neoplasm, these maps reveal that 2D sections overestimate immune exclusion, and resolve lymphoid aggregates in 3D. SpaReg, therefore, provides a scalable foundation for morphologically faithful, multimodal 3D atlases and spatially informed disease modeling

systems biology↗

TxCyto: A machine learning framework for estimating cytokine activity from whole transcriptome

Cytokines are critical mediators of intercellular communication, and a comprehensive characterization of their activity is essential for understanding health and disease. Existing tools to infer cytokine activity rely on experimental measurements. However, such measurements are available only for a small minority (43) of cytokines, and moreover, cytokine activity and response are highly context-specific, making a comprehensive experimental profiling across tissues, disease states, and biological contexts impractical. To address this gap, we developed TxCyto - a deep learning-based framework that infers the activity of cytokines, and more broadly of the tumor secretome, directly from the whole transcriptome profile of a sample. Trained on pan-cancer TCGA tumor transcriptomes, TxCyto was extensively validated in multiple independent datasets, including cytokine perturbation experiments. Across multiple cancer immunotherapy cohorts, TxCyto identified cytokines whose predicted activity was associated with therapeutic response. Furthermore, in spatial transcriptomic data for Liver cancer, TxCyto discovered spatial niches associated with response to immunotherapy. Overall, we develop a machine learning tool -TxCyto, for predicting the activity of 645 cytokines and tumor secretome from readily available whole transcriptomes. The TxCyto framework is generally applicable to other classes of regulatory molecules and TxCyto code base, and the tools are provided at https://github.com/Rahulncbs/TxCyto.

systems biology↗